Factors Affecting Family Satisfaction with Inpatient End-of-Life Care

Abstract

BackgroundLittle data exists addressing satisfaction with end-of-life care among hospitalized patients, as they and their family members are systematically excluded from routine satisfaction surveys. It is imperative that we closely examine patient and institution factors associated with quality end-of-life care and determine high-priority target areas for quality improvement.MethodsBetween September 1, 2010 and January 1, 2012 the Canadian Health care Evaluation Project (CANHELP) Bereavement Questionnaire was mailed to the next-of-kin of recently deceased inpatients to seek factors associated with satisfaction with end-of-life care. The primary outcome was the global rating of satisfaction. Secondary outcomes included rates of actual versus preferred location of death, associations between demographic factors and global satisfaction, and identification of targets for quality improvement.ResultsResponse rate was 33% among 275 valid addresses. Overall, 67.4% of respondents were very or completely satisfied with the overall quality of care their relative received. However, 71.4% of respondents who thought their relative did not die in their preferred location favoured an out-of-hospital location of death. A common location of death was the intensive care unit (45.7%); however, this was not the preferred location of death for 47.6% of such patients. Multivariate Poisson regression analysis showed respondents who believed their relative died in their preferred location were 1.7 times more likely to be satisfied with the end-of-life care that was provided (p = 0.001). Items identified as high-priority targets for improvement included: relationships with, and characteristics of health care professionals; illness management; communication; and end-of-life decision-making.InterpretationNearly three-quarters of recently deceased inpatients would have preferred an out-of-hospital death. Intensive care units were a common, but not preferred, location of in-hospital deaths. Family satisfaction with end-of-life care was strongly associated with their relative dying in their preferred location. Improved communication regarding end-of-life care preferences should be a high-priority quality improvement target.

Early Palliative Care Reduces End-of-Life Intensive Care Unit (ICU) Use but Not ICU Course in Patients with Advanced Cancer

“…There is a subset of advanced cancer patients who benefit greatly from ICU admission and for whom it is appropriate . However, avoiding ICU admission in the last months of life is a key goal for improving patient quality of life . We believe the CARE Track program reduced ICU use through several mechanisms.…”

Palliative Care and Cardiovascular Disease and Stroke: A Policy Statement From the American Heart Association/American Stroke Association

“…122 Caregivers who believed that their loved ones died in their preferred location were more satisfied with the patient's end-of-life care. 123 Efforts must be made to elicit patient preferences early in the disease course. The early elicitation of patient preferences may be especially important in the CVD population, considering the numerous options for diagnostic testing and advanced therapies even in end-stage disease.…”

Impact of provider level, training and gender on the utilization of palliative care and hospice in neuro-oncology: a North-American survey

“…SNO policies precluded us from tracking individual participants, sending repeat invitations, or incentivizing participation. There has been a shift towards assessing survey response rate by the potential for non-respondent bias, and whether the response population is representative of the population of interest [17], which is likely in our survey. While participants of the survey represent only a subset of all SNO participants; we believe that the respondents likely represent a larger proportion of clinical practitioners and overall the response rate is similar to other surveys exploring practice patterns in the field of neuro-oncology [18, 19].…”